Kodiak Sciences Inc. (KOD) Key Metrics

NASDAQ: KODValuation, returns, debt and efficiency ratios over 10 years.

KOD valuation today

Trailing 12 months · as of October 18, 2026
Market cap
$5.39B
Enterprise value
$2.05B
P/E (TTM)
—
Forward P/E
—
PEG ratio
—
Price / sales
—
Price / book
34.8
10-yr median 5.1
EV / EBITDA
—
Dividend yield
—
Beta
2.04

KOD key metrics, 2016–2025

Fiscal year ended December 31, 2025 · U.S. dollars

KOD valuation Price multiples at each fiscal year-end price.

Price / book+171.5%
9.5
2025 · hover or tap a bar for each year
2018: 2.92019: 7.9 (+168.9%)2020: 7.8 (−1.0%)2021: 6.6 (−15.2%)2022: 0.9 (−87.0%)2023: 0.6 (−30.1%)2024: 3.5 (+480.7%)2025: 9.5 (+171.5%)
20162025
Free cash flow yield+13.3 pts
−9.2%
2025 · hover or tap a bar for each year
2018: −11.6%2019: −1.5% (+10.2 pts)2020: −1.3% (+0.1 pts)2021: −5.6% (−4.2 pts)2022: −67.8% (−62.3 pts)2023: −122.8% (−54.9 pts)2024: −22.5% (+100.3 pts)2025: −9.2% (+13.3 pts)
20162025

KOD valuation history

Fiscal year-endToday10-year median

KOD returns on capital

ROEROICROA

Net income (ROE, ROA) or after-tax operating income (ROIC) divided by the average of the opening and closing balance.

KOD debt vs cash

Total debtCash & short-term investments

Debt includes short- and long-term borrowings and, where reported, lease liabilities.

KOD cash returned to shareholders

DividendsBuybacksFree cash flow

KOD price vs earnings per share

Share price at year-endEPS (right axis)

KOD key metrics

2016–2025
Kodiak Sciences Inc. key metrics by fiscal year
2025202420232022202120202019201820172016
Valuation
Market capitalization$1.49B$523.2M$159.3M$374.1M$4.39B$6.72B$2.72B$254.7M——
Enterprise value$1.44B$425.5M$55.5M$82.9M$3.84B$5.83B$2.39B$166.4M——
Price / book9.53.50.60.96.67.87.92.9——
Earnings yield−15.5%−33.7%−163.5%−89.2%−6.1%−2.0%−1.7%−16.3%——
Free cash flow yield−9.2%−22.5%−122.8%−67.8%−5.6%−1.3%−1.5%−11.6%——
Dividend yield———2.1%0.2%0.1%0.1%———
Shareholder yield (dividends + buybacks)———2.1%0.2%0.1%0.1%0.0%——
Share price at fiscal year-end$27.96$9.95$3.04$7.16$84.78$146.91$71.95$7.10——
Per share
Revenue per share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00—
Earnings per share−$4.32−$3.35−$4.97−$6.39−$5.16−$2.91−$1.25−$1.16−$1.05—
Operating cash flow per share−$2.56−$2.23−$2.94−$3.95−$3.52−$1.82−$1.03−$0.81−$0.66—
Free cash flow per share−$2.57−$2.24−$3.73−$4.86−$4.74−$1.98−$1.05−$0.83−$0.67—
Cash per share$3.94$3.20$5.45$9.17$14.12$21.18$8.89$2.46$0.05—
Book value per share$2.96$2.86$5.07$8.35$12.81$18.82$9.12$2.42−$2.59—
Tangible book value per share$2.96$2.86$5.07$8.35$12.81$18.82$9.12$2.42−$2.59—
Dividends per share———$0.15$0.19$0.14$0.06———
Capex per share$0.01$0.01$0.79$0.91$1.22$0.15$0.01$0.02$0.01—
Debt per share$2.99$1.34$3.47$3.59$3.47$1.69$0.05—$0.47—
Shares outstanding53.2M52.6M52.4M52.2M51.8M45.7M37.9M35.9M26.6M—
Change in shares outstanding+1.2%+0.3%+0.3%+0.9%+13.2%+20.8%+5.5%+35.1%——
Returns & profitability
Return on equity (ROE)−149.5%−84.7%−74.2%−60.7%−35.0%−22.1%−21.9%−458.1%——
Return on invested capital (ROIC)−232.5%−137.7%−142.8%−210.1%−521.4%—−827.5%———
Return on assets (ROA)−66.9%−43.2%−45.5%−42.5%−27.1%−18.7%−21.0%−86.9%−363.8%−141.4%
Return on tangible assets−65.4%−52.5%−54.3%−50.1%−29.5%−12.5%−13.2%−45.0%−861.2%−141.4%
Financial health
Total debt$159.2M$70.3M$181.6M$187.7M$179.9M$77.4M$1.9M—$12.4M$185,000
Cash & short-term investments$209.9M$168.1M$285.5M$478.9M$731.5M$969.0M$336.5M$88.3M$1.4M$9.6M
Net debt−$50.7M−$97.7M−$103.9M−$291.2M−$551.6M−$891.6M−$334.5M−$88.3M$11.0M−$9.4M
Debt / equity1.010.470.680.430.270.090.01———
Debt / assets0.450.210.380.280.200.070.01—3.820.02
Current ratio4.726.726.939.2611.3630.9328.9718.740.174.06
Quick ratio4.726.726.939.2611.3630.9328.9718.740.174.06
Interest coverage———————-4.8-21.5—
Working capital$169.3M$146.4M$247.6M$433.5M$670.1M$940.6M$327.5M$85.6M−$7.6M$7.7M
Invested capital$106.7M$52.6M$161.9M$145.0M$111.7M−$30.8M$10.8M−$1.4M−$57.8M−$50.5M
Tangible asset value$157.4M$150.3M$265.8M$436.2M$663.3M$860.8M$345.4M$86.8M−$68.7M−$41.1M
Net current asset value$20.7M−$13.4M$75.7M$255.5M$493.9M$765.4M$325.7M$85.1M−$70.4M−$43.0M
Graham net-net per share$0.30−$0.33$1.37$4.76$9.47$16.67$8.53$2.31−$2.66—
Capital allocation
Dividends paid———$7.9M$10.0M$6.2M$2.3M———
Share buybacks (net)———$0$0$487,000$132,000$0$0$0
Capex / depreciation0.020.011.604.317.271.660.481.190.383.00
Efficiency
Days payables outstanding—119.7159.9357.7441.6488.6735.01,641.01,472.61,525.3
Payables turnover—3.052.281.020.830.750.500.220.250.24
Asset turnover0.000.000.000.000.000.000.000.000.000.00
Average payables$8.4M$8.8M$11.4M$10.8M$10.5M$5.6M$1.8M$2.2M$2.2M$1.1M
Intangibles / total assets0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Computed from KOD's annual financial statements (latest annual report filed March 31, 2026) and the closing share price on each fiscal year-end, adjusted for stock splits. Figures in U.S. dollars; data from EODHD. Averages use the opening and closing balance of each year.

KOD valuation and financial ratios

Kodiak Sciences earned a return on equity of −149.5% and a return on invested capital of −232.5% in fiscal 2025. It ended the year with $159.2 million of debt and $209.9 million in cash and short-term investments, a net cash position of $50.7 million.

See the KOD income statement, the KOD chart for price history, or the KOD stock overview for the latest quote and news.

KOD key metrics FAQ

What is Kodiak Sciences's return on equity?

Kodiak Sciences's return on equity (ROE) was −149.5% in fiscal 2025: net income of -$230.0 million on average shareholders' equity of $153.8 million.

What is Kodiak Sciences's ROIC?

Kodiak Sciences's return on invested capital was −232.5% in fiscal 2025, using after-tax operating income divided by average debt plus equity minus cash.

How much debt does Kodiak Sciences have?

Kodiak Sciences had total debt of $159.2 million at the end of fiscal 2025, a debt-to-equity ratio of 1.01 and more cash than debt.

What is Kodiak Sciences's free cash flow yield?

Kodiak Sciences generated -$136.5 million of free cash flow in fiscal 2025, a free cash flow yield of −9.2% on its market value at year-end ($1.5 billion).

What is Kodiak Sciences's current ratio?

Kodiak Sciences's current ratio was 4.72 at the end of fiscal 2025: current assets were 4.72 times current liabilities.

Biotechnology key metrics